Maribel Parra

Avenida Gran Via 199
Barcelona, CT 08908, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

HDAC7 induction combined with standard-of-care chemotherapy provides a therapeutic advantage in t(4;11) infant B-cell acute lymphoblastic leukemia.

HDAC7 induction combined with standard-of-care chemotherapy provides a therapeutic advantage in t(4;11) infant B-cell acute lymphoblastic leukemia.

Journal: Biomarker research

Published: February 11, 2025

HDAC7 is a key factor for the germinal center reaction and its underexpression is associated with DLBCL prognosis.

HDAC7 is a key factor for the germinal center reaction and its underexpression is associated with DLBCL prognosis.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: February 01, 2025

The HDAC7-TET2 epigenetic axis is essential during early B lymphocyte development.

The HDAC7-TET2 epigenetic axis is essential during early B lymphocyte development.

Journal: Nucleic acids research

Published: July 29, 2021

Insights into the mechanisms underlying aberrant SOX11 oncogene expression in mantle cell lymphoma.

Insights into the mechanisms underlying aberrant SOX11 oncogene expression in mantle cell lymphoma.

Journal: Leukemia

Published: April 30, 2021

Epigenetic Control of Infant B Cell Precursor Acute Lymphoblastic Leukemia.

Epigenetic Control of Infant B Cell Precursor Acute Lymphoblastic Leukemia.

Journal: International journal of molecular sciences

Published: February 14, 2021

HDAC7 is a major contributor in the pathogenesis of infant t(4;11) proB acute lymphoblastic leukemia.

HDAC7 is a major contributor in the pathogenesis of infant t(4;11) proB acute lymphoblastic leukemia.

Journal: Leukemia

Published: July 14, 2020

MYC's Fine Line Between B Cell Development and Malignancy.

MYC's Fine Line Between B Cell Development and Malignancy.

Journal: Cells

Published: January 31, 2020

Genetics and epigenetics of leukemia and lymphoma: from knowledge to applications, meeting report of the Josep Carreras Leukaemia Research Institute.

Genetics and epigenetics of leukemia and lymphoma: from knowledge to applications, meeting report of the Josep Carreras Leukaemia Research Institute.

Journal: Hematological oncology

Published: January 31, 2020

From Loops to Looks: Transcription Factors and Chromatin Organization Shaping Terminal B Cell Differentiation.

From Loops to Looks: Transcription Factors and Chromatin Organization Shaping Terminal B Cell Differentiation.

Journal: Trends in immunology

Published: July 10, 2019

In vivo conditional deletion of HDAC7 reveals its requirement to establish proper B lymphocyte identity and development.

In vivo conditional deletion of HDAC7 reveals its requirement to establish proper B lymphocyte identity and development.

Journal: The Journal of experimental medicine

Published: May 14, 2015

The transcriptional repressor HDAC7 promotes apoptosis and c-Myc downregulation in particular types of leukemia and lymphoma.

The transcriptional repressor HDAC7 promotes apoptosis and c-Myc downregulation in particular types of leukemia and lymphoma.

Journal: Cell death & disease

Published: August 26, 2014

Class IIa HDACs - new insights into their functions in physiology and pathology.

Class IIa HDACs - new insights into their functions in physiology and pathology.

Journal: The FEBS journal

Published: July 11, 2014

Showing 1-12 of 19

Last Updated: 09/26/2026